NCT01015079

Brief Summary

To investigate the protective effect of cervical cancer incidence and mortality by screening attending frequency or screening pattern, and to evaluate the possible risk of developing malignancies among women with cervical lesions, inflammation or infection.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,000,000

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 17, 2009

Completed
Last Updated

November 17, 2009

Status Verified

November 1, 2009

First QC Date

November 16, 2009

Last Update Submit

November 16, 2009

Conditions

Cervical CancerCancer

Keywords

Pap smear screening

Study Arms (1)

Entire Taiwan women

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The entire Taiwan women with their information obtained from several national registries.

The eligibility criteria in the proposal are specified in different part of analyses respectively, which are briefly listed below: Part I: * Include women covered by national screening program and they did not have previous cervical cancer history before the study initiate date. Part II: * Include women ever participated cervical cancer screening and exclude women with previous cervical cancer history before screening attending. Part III: * Include women without previous cervical cancer history before the follow-up initiation. Part IV: * Include women without previous cervical cancer history before the follow-up initiation.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Taiwan Cervical Cancer Screening Task Force

Taipei, 10055, Taiwan

RECRUITING

Related Publications (1)

  • Cheng WF, Chen YL, You SL, Chen CJ, Chen YC, Hsieh CY, Chen CA. Risk of gynaecological malignancies in cytologically atypical glandular cells: follow-up study of a nationwide screening population. BJOG. 2011 Jan;118(1):34-41. doi: 10.1111/j.1471-0528.2010.02769.x. Epub 2010 Nov 4.

    PMID: 21054764DERIVED

MeSH Terms

Conditions

Uterine Cervical NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Chi-An Chen, MD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yun-Yuan Chen, PhD

CONTACT

+886 2 23910409b87801006@ntu.edu.tw

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 16, 2009

First Posted

November 17, 2009

Study Start

November 1, 2009

Last Updated

November 17, 2009

Record last verified: 2009-11

Locations

TW(1)